Eli Lilly and Company (LLY) — closed signal from April 2, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 1, 2026.
Predicted vs. what happened
LLY price · publication thesis → realized outcomesplit-adjusted
$930.00 – $955.00Entry zone — fair-value band
$952.56Published — price the day we called it
$1,085.92Target — the price the thesis aimed for
$1,238.00Peak — highest point inside the window, not a realized return
$1,191.74Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 55 days.
Peak price
$1,238.00
peak on June 29, 2026 — not a realized returnPeak gain
+30%
peak, from the publication priceWindow close
$1,191.74
end-of-window price, context onlyDays to target
55
Window
April 2, 2026 – July 1, 2026
The thesis — published April 2, 2026
Predicted growth
+14%
over the measurement windowTarget price
$1,085.92
the price the thesis aimed forEntry zone
$930.00 – $955.00
the fair-value band we waited forPrice at publication
$952.56
published April 2, 2026Confidence
80%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Eli Lilly looks like a relatively steady growth option for the next few months because a new obesity drug launch on April 6 keeps attention on its leadership in that area and pushes sales estimates higher. Good trial results also back up the wider drug pipeline. Shares have run up, so a calmer rise after a small pullback feels safer than chasing higher prices now.
Primary drivers
- April 6 drug launch keeps obesity leadership visible and may lift sales
- Positive trial results make the broader drug pipeline more credible
- Health-care stock traits can steady returns when markets swing
- A pullback into the entry band looks safer than buying after the rally
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.